(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ABDIIBRAHIM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ABDIIBRAHIM

ST13

US500000090064573

Class

5

Filing

90064573

Registration

6662343

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

04/29/2022

Trademark type

Combined

Nice classes

5

Filing date

07/21/2020

Registration date

03/08/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/08/2022

Last transaction

04/29/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

09

Owner location

Sariyer Istanbul, TR

Examiner

FLETCHER, TRACY

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of three concentric circles divided in half where the center circle is blue on the left side and white on the right side, the next circle is white on the left side and blue on the right side and the outer circle is blue on the left side and white on the right side and is outlined in blue on the outer right side. The circle design appears to the left of the wording "ABDIIBRAHIM" in gray stylized font. The remaining white represents background and does not form part of the mark.

Holders and representatives

Holders

Abdi Ibrahim Ilaç Sanayi ve Tic A.S.

Representatives

Jefferson F. Scher CARR & FERRELL LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations used for the treatment of bonejointvertebral columnintestinecolonskinlungeyebreastovarycervixstomachbladderkidneyheadbrainneckblood diseases and disorders; pharmaceutical preparations for the treatment of autoimmuneimmune systeminflammatoryinflammatory bowelgastrointestinalgenitourinarymusculoskeletalmusculardermatologicalpulmonaryrespiratoryoncologicalhepatologicalviralmetabolicendocrinecardiovascularcardiopulmonarysexual dysfunctionophthalmicneurologicalhormonalpsychiatric diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of dermatologicalcardiovascularhematologicalbonerespiratorycentral nervous systemendocrinologicalcirculatorygastroenterologicalstomachdigestivehormonaldiabeticmuscularrheumaticimmune systemocular and metabolic diseases and disorders; pharmaceutical preparations to treat or prevent diabetescoughscoldsinfluenzaheadaches and allergic reactions; anti-infectives; anti-inflammatories; vaccines; dietetic substances for medical purposesnutritionalvitamin and mineral supplements and preparations; antiallergic medicinesantidiarrheal medicinesmedicines for intestinal disordersmotion sickness medicinesmedicines for the treatment of gastrointestinal diseases; medicines for the treatment of cardiovascular and cerebrovascular diseases; prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders; medicinal herbal preparations; medicinal preparations for the treatment of diseases of the mouth in the form of sprays; medicinal creams for skin care; propolis for medicinal or therapeutic purposes; medicinal preparations for the treatment of infectious diseases and for use in oncology; medicinal preparations for the treatment of diseases of the mouth to be applied in the form of dropscapsulestablets and compressed tablets; medicinal syrups for the treatment of coldnasal and ocular allergic rhinitischronic idiopathic urticariaacute and dry coughchronic feverachronic hemodialyseshyperthyroidliver and gall bladder disorderssudden weight lossnon-adequate and non-balanced nutritionmouth and throat disordersmalaise and fatiguehyozincemiarespiratory infectionstreatment of zinc and iron insufficiencytreatment of irritation of throat and bronchustreatment of bipolar manic episode; vitamin and mineral supplements; medicinal syrups containing sodium saccarineglycerinebanana aromastrawberry aromafruit aromaorange flavoursucralosenicotimanidfish oilpelargonium sidoidesxanthan gumbubble gum aromared food dyepeach aromayellow food dyeraspberry extractindigo blue food dyecaramel for the treatment of coldnasal and ocular allergic rhinitischronic idiopathic urticariaacute and dry coughchronic feverachronic hemodialyseshyperthyroidliver and gall bladder disorderssudden weight lossnon-adequate and non-balanced nutritionmouth and throat disordersmalaise and fatiguehyozincemiarespiratory infectionstreatment of zinc and iron insufficiencytreatment of irritation of throat and bronchustreatment of bipolar manic episode; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; anti-infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; pharmaceutical skin lotions; pharmaceutical preparations for skin care; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for treating hypertension; pharmaceutical antitussive-cold preparations; pharmaceutical preparations for skin wounds; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for treating asthma; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for treating diseases and disorders of the central nervous system; pharmaceutical preparations for treating allergic rhinitis and asthma; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; all of the foregoing being medicines for human health

Publications

History of USPTO decisions and trademark events.

23 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

03/08/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/21/2021

PUBO

PUBLISHED FOR OPPOSITION

12/21/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/01/2021

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

11/16/2021

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

11/12/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/09/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/09/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/09/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

11/09/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/10/2021

GNFR

FINAL REFUSAL E-MAILED

05/10/2021

CNFR

FINAL REFUSAL WRITTEN

05/10/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/05/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/04/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/04/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/04/2020

GNRT

NON-FINAL ACTION E-MAILED

11/04/2020

CNRT

NON-FINAL ACTION WRITTEN

11/04/2020

DOCK

ASSIGNED TO EXAMINER

11/04/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/19/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/18/2020

NWAP

NEW APPLICATION ENTERED

07/24/2020

Continuous trademark protection

Get notified about every new filing that threatens ABDIIBRAHIM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.